TKTL1 and cancer: Combination of EDIM-TKTL1 and EDIM-Apo10 tests showed 100% sensitivity, 96.2% specificity and an AUC of 0.9934 for cancer detection. A positive result was seen for 100% of all cancer patients, 0% of healthy individuals, and 7.7% of individuals with inflammation.